VF
DMRA

Virtu Financial’s Damora Therapeutics DMRA Stock Holding History

Virtu Financial’s Portfolio DMRA Stock Details DMRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$203K Buy
+7,799
New +$189K 0.01% 928
2025
Q4 		– Sell
-13,128
Closed -$49K – 1863
2025
Q3 		$49K Buy
+13,128
New +$44.5K ﹤0.01% 1136
2024
Q3 		– Sell
-587
Closed -$7K – 1557
2024
Q2 		$7K Buy
+587
New +$9.27K ﹤0.01% 1161
2021
Q4 		– Sell
-983
Closed -$88K – 1884
2021
Q3 		$88K Buy
983
+468
+91% +$50K 0.01% 1176
2021
Q2 		$65K Buy
+515
New +$70.2K 0.01% 1289

Other funds holding DMRA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
RCP
Remedium Capital Partners Fort Lauderdale, Florida $452M AUM

Virtu Financial's DMRA Position: Q2 2026 in Review

Virtu Financial opened a new position in Damora Therapeutics (DMRA) in Q2 2026: 7,799 shares worth $203K. The stake represents 0.01% of the portfolio and ranks #928 among its holdings. This is a return to the name: Virtu Financial previously reported a position in DMRA as recently as Q3 2025.

Virtu Financial first reported a position in DMRA in Q2 2021 and has held it in 5 quarters since. 104 funds tracked by Wall St. Rank hold DMRA as of Q2 2026.

  • Virtu Financial held 7,799 shares of Damora Therapeutics worth $203K as of Q2 2026.
  • Damora Therapeutics was a new Virtu Financial position in Q2 2026.
  • Damora Therapeutics made up 0.01% of Virtu Financial's portfolio in Q2 2026, its #928 holding.
  • Virtu Financial first reported a position in Damora Therapeutics in Q2 2021 and has held it in 5 quarters since.
  • 104 funds tracked by Wall St. Rank held Damora Therapeutics as of Q2 2026.

Based on Virtu Financial's 13F filing for Q2 2026, filed 13 Aug 2026.